Evidence map›Paper›PMID 40463648›Full record

ReviewDiscovery immunology2025

The immunological role of oligodendrocytes: beyond myelin maintenance.

Juana M Pasquini, Jorge D Correale

Abstract readReview
In one paragraph

Review in Discovery immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Juana M PasquiniDepartamento de Química Biológica e Instituto de Química y Fisiscoquímica Biológica IQUIFIB Facultad de Farmacia y Bioquímica Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0001-7683-0228
Jorge D CorrealeInstituto de Química y Fisicoquímica Biológica IQUIFIB Facultad de Farmacia y Bioquímica Universidad de Buenos Aires-CONICET Argentina y, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0003-4756-9889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligodendrocytes (OGDs) are well-established cells in the central nervous system (CNS), primarily recognized for their role in myelination. However, emerging evidence suggests intrinsic differences among OGDs that may lead to diverse functions. OGDs heterogeneity could depend on their origin, location, age, and the presence of pathology. These variations indicate that specific populations of OGDs can modulate local immune responses and interact with other immune cells beyond their role in myelination. OGDs express major histocompatibility complex class I and class II molecules and can thus present endogenous and exogenous antigens to CD8 + and CD4 + T cells, respectively. In physiological conditions, OGDs release factors that maintain microglial quiescence and support homeostatic functions. However, during neuroinflammation, OGDs interact with microglia, astrocytes, and peripheral immune cells infiltrating the CNS, which may change their signaling profiles. In inflammatory conditions, OGDs demonstrate their active role in CNS immunology by producing a range of pro-inflammatory cytokines and chemokines. These factors are critical to the regulation of immune cell migration and activation within the CNS. Conversely, OGDs can also release anti-inflammatory factors, such as brain-derived neurotrophic factors, which help mitigate excessive inflammatory responses. Research into how OGDs affect and are affected by neighboring cells may unveil new therapeutic targets and strategies. The dual roles of OGDs in immunology and CNS function present both opportunities and challenges for advancing our understanding and treatment of CNS disorders.

Indexed as

chemokinescytokinesmajor histocompatibility complexneuroinflammationoligodendrocytes

Identifiers

PMID40463648
PMCPMC12131160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.